» Advanced search
Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 1-1 of 1 results.
 
{{ selectedCountPage }} items selected on this page, {{ selectedCountPage }} item selected on this page, {{ selectedCountTotal }} item in total {{ selectedCountTotal }} items in total
Study aim: Determining the effect of Persian medicine products on O2 saturation in patients with or suspected of COVID-19 Determining the Effect of Persian medicine products on Respiratory Rate in Patients With or Suspected of COVID-19 The effect of Persian medicine products on CRP levels of patients with or suspected of COVID-19 The effect of Persian medicine products on lymphocyte levels in patients with or suspected of COVID-19 Determining the effect of Persian medicine products on WBC levels in patients with or suspected of COVID-19 Design: A randomized clinical trial with two group: control and intervention Settings and conduct: The study will be conducted at Imam Reza Hospital. Patients will be randomly divided into intervention and control groups. Given the open-label study, Blinding will not happen. Participants/Inclusion and exclusion criteria: Patients over 18 years old hospitalized with or suspected of COVID-19: Liver, kidney and heart failure, Immunodeficiency, Pregnancy and breast feeding, Hypertension, Alcohol or drug addiction, A history of allergies to medicinal herbs, Patients with transplanted organs, Cor Pulmonel Patients, History of deep vein thrombosis Intervention groups: Intervention group: standard treatment, Persian medicine capsule, Persian medicine syrup Control group: standard treatment Main outcome variables: Oxygen saturation: Respiratory Rate
IRCTID: IRCT20140617018126N2
Loading...